Khosla, VCs plow US$100m into blood test startup using AI

Khosla, VCs plow US$100m into blood test startup using AI
(Image: Bloomberg)
Bloomberg
(Bloomberg) -- Blood-testing company Karius Inc. raised US$100 million (NZ$166.8m) in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals. The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation. Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic reference...

More Technology

Will AI destroy us?
Technology

Will AI destroy us?

As an extension of human intelligence, AI reflects our own selves.

2025 TVs force buyers to pick their perfect picture
The Life Review

2025 TVs force buyers to pick their perfect picture

Many models are now available with healthy discounts before Christmas.

Peter Griffin 26 Oct 2025
The boom that can’t last forever
Opinion

Eden Bradfield: The boom that can’t last forever

Artificial intelligence – it IS a bubble.

Eden Bradfield 25 Oct 2025
Don't get stuck in Big Tech's ecosystem
Technology Spark Accelerate

Don't get stuck in Big Tech's ecosystem

Amanda Johnstone's warning for Kiwi businesses.

Peter Griffin 24 Oct 2025